MGUS to Myeloma: Study Suggests Risk of Progression Can Change
08/13/2019
	A person’s risk of progressing from a benign condition called monoclonal gammopathy of undetermined significance (MGUS) to the blood cancer multiple myeloma can change over time, according to a new study.

		National Cancer Institute theNCI	14 Aug
		RT @NCIDataSci: August 22 is the last day to submit a proposal to build the @theNCI #CancerData Aggregator that will allow users to query a…
		Details  |  Retweet

---

		National Cancer Institute theNCI	14 Aug
		Recommendations on lung cancer screening may need to be reviewed for African Americans who smoke, a new study sugge… https://t.co/NrLd2BJEHH
		Details  |  Retweet

---

		National Cancer Institute theNCI	13 Aug
		Applications for the NCI Research Specialist Award (R50) are due October 18. Core facility managers, data scientist… https://t.co/sD9rZOdBiY
		Details  |  Retweet

---

		National Cancer Institute theNCI	13 Aug
		RT @NCICancerStats: You can see UV Exposure by county here: https://t.co/NE6S3CGvul https://t.co/Aaa7rOLuqi
		Details  |  Retweet

---

		NCI Media Relations NCIMedia	13 Aug
		Article by @MarilynnL @Reuters_Health @Medscape on @NCIEpiTraining study published in @JAMAOnc finding that elderly… https://t.co/THH6QVRzf7
		Details  |  Retweet

---

		National Cancer Institute theNCI	13 Aug
		HPV vaccines are highly effective in preventing infection with the types of human papillomaviruses (#HPV) they targ… https://t.co/TeHlWo4VG7
		Details  |  Retweet